Join the Lennox-Gastaut Syndrome group to help and get support from people like you.
Lennox-Gastaut Syndrome News
Experimental Drug XEN1101 Could Rein in Epilepsy Seizures
TUESDAY, Oct. 10, 2023 – For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them....
Surgery Offers Survival Benefit for Pediatric Drug-Resistant Epilepsy
TUESDAY, June 20, 2023 – For pediatric patients with drug-resistant epilepsy, vagus nerve stimulation (VNS) or cranial epilepsy surgery offers a survival benefit compared with antiseizure...
Fintepla (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
Fintepla® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle tone, become limp, and fall to the ground, ...
FDA Approves Sympazan (clobazam) Oral Film for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
WARREN, N.J., Nov. 2, 2018 /PRNewswire/ – Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Epidiolex (cannabidiol) to Treat Lennox-Gastaut Syndrome and Dravet Syndrome
June 25, 2018 – The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy,...
Eisai Receives Approval for Antiepileptic Drug Banzel (rufinamide) As Adjunctive Treatment For Pediatric Patients
Tokyo, Japan – February 16, 2015 – Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has received approval of an additional pediatric indication for Eisai’s antiepileptic drug (...
FDA Medwatch Alert: Onfi (clobazam): Drug Safety Communication - Risk of Serious Skin Reactions
ISSUE: FDA is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death. FDA approved changes to the Onfi...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
Klonopin, clonazepam, Lamictal, Topamax, lamotrigine, topiramate, cannabidiol